The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 28 February 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 196K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helgason, C. D.
Right arrow Articles by Humphries, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helgason, C. D.
Right arrow Articles by Humphries, R. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/3/781/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 5, March 6, 2000 781-794


Original Article

A Dual Role for Src Homology 2 Domain–containing Inositol-5-Phosphatase (SHIP) in Immunity: Aberrant Development and Enhanced Function of B Lymphocytes in SHIP-/- Mice

Cheryl D. Helgasona, Christian P. Kalberera, Jacqueline E. Damena, Suzanne M. Chappela, Nicolas Pineaulta, Gerald Krystala,b, and R. Keith Humphriesa,c
a Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada
b Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
c Department of Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada

Correspondence to: R. Keith Humphries, Terry Fox Laboratory, 601 W. 10th Ave., Vancouver, British Columbia V5Z 1L3, Canada. Tel:604-877-6070 Fax:604-877-0712 E-mail:keith{at}terryfox.ubc.ca.

Released online: 28 February 2000

In this report, we demonstrate that the Src homology 2 domain–containing inositol-5-phosphatase (SHIP) plays a critical role in regulating both B cell development and responsiveness to antigen stimulation. SHIP-/- mice exhibit a transplantable alteration in B lymphoid development that results in reduced numbers of precursor B (fraction C) and immature B cells in the bone marrow. In vitro, purified SHIP-/- B cells exhibit enhanced proliferation in response to B cell receptor stimulation in both the presence and absence of Fc{gamma} receptor IIB coligation. This enhancement is associated with increased phosphorylation of both mitogen-activated protein kinase and Akt, as well as with increased survival and cell cycling. SHIP-/- mice manifest elevated serum immunoglobulin (Ig) levels and an exaggerated IgG response to the T cell–independent type 2 antigen trinitrophenyl Ficoll. However, only altered B cell development was apparent upon transplantation into nonobese diabetic–severe combined immunodeficient (NOD/SCID) mice. The in vitro hyperresponsiveness, together with the in vivo findings, suggests that SHIP regulates B lymphoid development and antigen responsiveness by both intrinsic and extrinsic mechanisms.

Key Words: signal transduction, B cell receptor, Fc{gamma}RIIB, immunoglobulin, antigen response


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS